Nothing Special   »   [go: up one dir, main page]

EP2457661A1 - Dispositif de support pour membrane de mise en place fluidique biologique séchée et procédés associés - Google Patents

Dispositif de support pour membrane de mise en place fluidique biologique séchée et procédés associés Download PDF

Info

Publication number
EP2457661A1
EP2457661A1 EP11186685A EP11186685A EP2457661A1 EP 2457661 A1 EP2457661 A1 EP 2457661A1 EP 11186685 A EP11186685 A EP 11186685A EP 11186685 A EP11186685 A EP 11186685A EP 2457661 A1 EP2457661 A1 EP 2457661A1
Authority
EP
European Patent Office
Prior art keywords
membrane
biological fluid
window
pocket
face
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP11186685A
Other languages
German (de)
English (en)
Inventor
Ivan Hulka
Maha Yamak
Robert Lee Grenz
Wilford Downs
William C. Hudson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Agilent Technologies Inc
Original Assignee
Agilent Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agilent Technologies Inc filed Critical Agilent Technologies Inc
Publication of EP2457661A1 publication Critical patent/EP2457661A1/fr
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L9/00—Supporting devices; Holding devices
    • B01L9/52—Supports specially adapted for flat sample carriers, e.g. for plates, slides, chips
    • B01L9/523—Supports specially adapted for flat sample carriers, e.g. for plates, slides, chips for multisample carriers, e.g. used for microtitration plates
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/18—Transport of container or devices
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/06—Auxiliary integrated devices, integrated components
    • B01L2300/069—Absorbents; Gels to retain a fluid
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/08—Geometry, shape and general structure
    • B01L2300/0809—Geometry, shape and general structure rectangular shaped
    • B01L2300/0822—Slides
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/08—Geometry, shape and general structure
    • B01L2300/0887—Laminated structure

Definitions

  • the present invention relates generally to dried biological fluid spot testing. More particularly, the present invention relates to devices and methods for holding dried biological fluid spotting membranes.
  • DBS dried biological fluid spot testing
  • Collection sites for clinical trials may sample blood spots (or other types of biological fluid spots) in the field, allow the spots to dry, and then ship the spots at a lower cost than liquid samples due to the non-biohazard status of dried blood spots and the less rigorous requirements for temperature control.
  • Blood spotting is also becoming useful in preclinical work as analytical chemists are required to store samples for Incurred Sample Reanalysis (ISR) studies, and dried blood spots have proven to be an effective way to stabilize the analytes and the matrix.
  • ISR Incurred Sample Reanalysis
  • DBS samples are prepared by applying drops of blood drawn from a finger or toe to an absorbent membrane or substrate (e.g., filter paper) of an appropriate composition.
  • the blood saturates the membrane and is air dried for a period of time (e.g., several hours) sufficient to form an array of circular dried blood spots on the membrane.
  • the spot-containing membrane (which, as described below, is typically housed in a cardboard holder) may then be stored in a plastic container and transported as needed without needing to be frozen.
  • the dried blood spots may thereafter be separated from the bulk membrane by punching the dried blood spots to create individual dried blood spot disks.
  • Analytes such as pharmaceutical compounds may then be extracted from the dried blood spots by any number of techniques and subjected to analytical testing. Other types of biological fluid samples may be dried and subsequently processed in an analogous manner.
  • the absorbent membrane is housed in a membrane holder that is made of cardboard or chipboard.
  • the absorbent membrane is sandwiched between a top cardboard face and a bottom cardboard face.
  • the top face is secured to the bottom face by adhesive.
  • a user may access the absorbent membrane via a window that passes through the top face and/or the bottom face.
  • Conventional cardboard holders have many problems. For instance, cardboard can bend or warp easily (during testing, handling, shipping, etc.) which can impede the uniformity of the absorbent membrane. As another example, chemicals in the adhesives used to secure the top cardboard face to the bottom cardboard face may contaminate blood samples on the absorbent membrane. Also, conventional cardboard holders are generally not reusable.
  • the present disclosure provides methods, processes, systems, apparatus, instruments, and/or devices, as described by way of example in implementations set forth below.
  • a holding device for a dried biological fluid spotting membrane includes a plastic top face, a plastic bottom face, and a pocket disposed between the top face and the bottom face.
  • the plastic top face includes a window formed therein, and the window has a length and a height.
  • the pocket has a length and a height, and is configured for receiving a dried biological fluid spotting membrane that is accessible through the window by a user during dried biological fluid spot testing.
  • the length of the window is less than the length of the pocket, and the height of the window is less than the height of the pocket.
  • the window of the top face is a first window and the bottom face comprises a second window formed therein.
  • the second window has a length that is substantially the same as the length of the first window, and a height that is substantially the same as the height of the first window.
  • the holding device includes a plastic laminate layer and a plastic body.
  • the plastic laminate layer includes the top face.
  • the plastic body includes the bottom face and an opposing inner face. The laminate layer is adhered to the inner face.
  • the holding device includes a plastic top piece and a plastic bottom piece.
  • the plastic top piece includes the top face and a first inner face opposing the top face.
  • the first inner face includes a plurality of male components extending from the first inner face.
  • the plastic bottom piece includes the bottom face and a second inner face opposing the bottom face.
  • the second inner face includes a plurality of female components extending into the second inner face.
  • the female components are configured for detachably mating with the male components.
  • a method for assembling a holding device.
  • a dried biological fluid spotting membrane is positioned within a pocket of a plastic membrane housing.
  • the membrane is secured within the pocket, and is accessible by a user via a window formed in a top face of the plastic membrane housing.
  • securing the membrane within the pocket includes overmolding a top piece onto an inner face of the plastic membrane housing.
  • the inner face includes the pocket formed therein, and the top piece includes the top face.
  • securing the membrane within the pocket includes adhering a plastic laminate layer to an inner face of the plastic membrane housing.
  • the plastic laminate layer includes the top face.
  • securing the membrane within the pocket includes detachably mating male components extending from a first inner face of a top piece with female components extending into a second inner face of a bottom piece of the membrane housing.
  • the top piece includes the top face and the first inner face opposing the top face.
  • the bottom piece includes a bottom face and the second inner face opposing the bottom face.
  • the second inner face includes the pocket formed therein.
  • a method for using a holding device in which a membrane is secured in a pocket of the holding device.
  • a dried biological fluid spot is formed on the membrane by accessing the membrane via a window of the holding device, applying a drop of a biological fluid sample to the membrane to form a biological fluid spot, and allowing the biological fluid spot to dry.
  • the method includes accessing the dried biological fluid spot via the window and extracting a portion of the dried biological fluid spot formed on the membrane.
  • the method includes removing the top piece from the bottom piece by detaching male components from female components.
  • the membrane may be removed from the pocket.
  • the removed membrane may be replaced with a second dried biological fluid spotting membrane by positioning the second membrane within the pocket.
  • the second membrane may be secured within the pocket by detachably mating the male components and the female components.
  • FIG. 1 is an exploded view of an example of a holding device for a dried biological fluid spotting membrane according to an implementation disclosed herein.
  • FIG. 2A is a plan view of a top face of a top piece of the holding device illustrated in FIG. 1 .
  • FIG. 2B is a plan view of a first inner face opposite the top face illustrated in FIG. 2A .
  • FIG. 2C is a side cross-sectional elevation view of a male component illustrated in FIG. 2B .
  • FIG. 3A is a plan view of a second inner face of a bottom piece illustrated in FIG. 1 , shown without the dried biological fluid spotting membrane.
  • FIG. 3B is a side cross-sectional elevation view of the bottom piece illustrated in FIG. 3A .
  • FIG. 4 is an exploded view of another example of a holding device for the dried biological fluid spotting membrane according to an implementation disclosed herein.
  • FIG. 5 is a perspective view of another example of a holding device for the dried biological fluid spotting membrane according to the present invention.
  • fluid refers generally to liquid-phase materials and gas-phase materials, unless a liquid-phase material or a gas-phase material is specifically indicated.
  • liquid-phase and “liquid,” and “gas-phase” and “gas,” are used interchangeably.
  • a liquid-phase material or liquid may be any liquid, such as a solution, suspension, slurry, multi-phase mixture or the like, and may include gaseous components (e.g., bubbles) and/or solid components (e.g., particles).
  • a gas-phase material or gas may be any gas or vapor, and may include liquid components (e.g., droplets) and/or solid components (e.g., particles).
  • a “dried fluid sample” or a “dried fluid spot” refers generally to a material that was initially provided in the liquid phase and was thereafter dried, such as by air drying.
  • analyte refers generally to any sample molecule of interest-that is, a molecule on which an analysis is desired such as, for example, a chromatographic analysis.
  • FIGS. 1-5 Examples of implementations of the subject matter disclosed herein will now be described in more detail with reference to FIGS. 1-5 .
  • FIG. 1 is an exploded view of an example of a holding device (or “membrane housing") 100 for a dried biological fluid spotting membrane (or “substrate,” or “card”) 102 according to an implementation of the present teachings.
  • a holding device or “membrane housing” 100 for a dried biological fluid spotting membrane (or “substrate,” or “card”) 102 according to an implementation of the present teachings.
  • biological fluids that may be formed into dried biological fluid spots using the membrane 102 include, but are not limited to, blood-based samples such as whole blood, plasma or serum.
  • the spot-containing membrane 102 is often termed a dried blood spotting card. It will be appreciated, however, that biological fluids formable into dried spots are not limited to blood-based samples.
  • the membrane 102 may be made of any composition suitable for use as a spotting card, non-limiting examples of which include various types of cellulosic filter papers, glass fiber/cellulose composites, cellulose-free glass fiber paper, polyamides (e.g., nylon), propylene, nitrocellulose, polyethersulfone, etc. Further examples of membrane compositions are described in U.S. Patent Application No. 12/860,669 , titled DRIED BLOOD SPOTTING PAPER DEVICE AND METHOD, filed August 20, 2010, which is incorporated by reference herein in its entirety.
  • the membrane 102 material is able to uniformly absorb a biological fluid sample to form a homogeneous circular spot. Indicia such as dashed circles may be provided on the membrane 102 for assisting in placement of multiple biological fluid samples when it is desired to form an array of dried biological fluid spots.
  • the indicia may include printed matter, perforations and/or scoring.
  • the holding device 100 may include a plastic top piece 104, a plastic bottom piece 106, and a pocket 108 configured for receiving the membrane 102.
  • the top piece 104 and the bottom piece 106 may generally be made of any suitable plastic material capable of being injection molded or formable by any other suitable fabrication technique. Examples of suitable plastic materials include, but are not limited to, polypropylene, polyethylene, other polyolefins, polyamide, polyacrylate, and the like. As injection molding of plastic materials is widely known to those of skill in the art, a detailed discussion of the injection molding process will not be discussed in detail in the present disclosure.
  • the top piece 104 may include a top face 110, a first inner face (see FIG.
  • a first window 112 formed between the top face 110 and the first inner face 220 is not intended to limit the method by which the first window 112, the top face 110, or the first inner face 220 is formed.
  • a mold for the top piece 104 may be designed such that when the plastic material is injected into the mold, a protrusion in the mold may form the first window 112 between the top face 110 and the first inner face 220.
  • appropriate tools may be used to cut the first window 112 between the top face 110 and the first inner face 220.
  • the first window 112 has a length and a height. To more easily describe dimensions of various components of the present invention, lengths and heights of the various components will be described in relation to horizontal and vertical axes. Although the cross-sections of the holding devices 100 (and holding devices 400 and 500 discussed below in conjunction with FIGS. 4-5 ) described herein are rectangular in shape, it will be understood that the cross-sections of the holding devices 100, 400 and 500 (as well as the shapes of windows described herein) may be any suitable shape, such as circular, polygonal, elliptical, etc.
  • the length of the first window 112 is measured along a horizontal axis 114 , and is the distance between a first side wall 116 and a second side wall 118 of the first window 112 .
  • the height of the first window 112 is measured along a vertical axis 120 , and is the distance between a top wall 122 and a bottom wall 124 of the first window 112 .
  • the first window 112 allows a user to access the membrane 102 when the top piece 104 is secured to the bottom piece 106 .
  • FIG. 2A is a plan view of the top face 110 of the holding device 100 illustrated in FIG. 1 .
  • FIG. 2B is a plan view of the first inner face 220 , which is opposite the top face 110 illustrated in FIG. 2A .
  • the first inner face 220 may include a plurality of male components 226a - 226d extending from the first inner face 220 .
  • the male components 226a - 226d are configured for detachably mating with corresponding female components (see FIGS. 1 and 3A-3B , elements 126a - 126d ) extending into a second inner face 128 .
  • the male components 226a - 226d may not be visible from the top face 110 .
  • the broken lines formed into circles on the top face 110 in FIG. 2A illustrate where the male components 226a - 226d are positioned on the first inner face 220 relative to the top face 110 .
  • the holding device 100 in the present implementation includes four male components 226a - 226d and four corresponding female components 126a - 126d , it will be understood that the holding device 100 may include any suitable number of male components 226a - 226d and corresponding female components 126a - 126d , and the male components 226a - 226d and female components 126a - 126d may be positioned in any suitable place on the first inner face 220 and the second inner face 128, respectively.
  • the first inner face 220 may include female components 126a - 126d extending into the first inner face 220
  • the second inner face 128 may include male components 226a - 226d extending from the second inner face 128.
  • FIG. 2C is a side cross-sectional elevation view of the male component 226c illustrated in FIG. 2B .
  • the male component 226c may include a compressible portion 230 such as a collar that is configured for compressing as the male component 226c is pressed or otherwise detachably secured within the corresponding female component 126c.
  • the compressible portion 230 may be compressed by force imparted by the inner wall(s) of the female component 126c, which may result in an interference fit, friction fit, press fit, or the like between the male component 226c and the corresponding female component 126c.
  • FIG. 1 is a side cross-sectional elevation view of the male component 226c illustrated in FIG. 2B .
  • the male component 226c may include a compressible portion 230 such as a collar that is configured for compressing as the male component 226c is pressed or otherwise detachably secured within the corresponding female component 126c.
  • the compressible portion 230 may be compressed by force imparted by the inner wall
  • the compressible portion 230 may include two or more segments separated by a gap that are movable relative to each other when force is imparted to one or more of the segments.
  • the other male components 226a, 226b and 226d may be configured substantially identical to male component 226c.
  • the bottom piece 106 of the holding device 100 includes the second inner face 128 and a bottom face (see FIG. 3B , element 340).
  • the second inner face 128 may include the female components 126a - 126d extending into the second inner face 128.
  • the female components 126a - 126d have hexagonal cross-sections. It will be understood that the female components 126a - 126d may include any suitable cross-sectional shape, so long as the female components 126a - 126d are configured for detachably receiving the corresponding male components 226a - 226d.
  • the female components 126a - 126d may extend into the second inner face 128 a selected depth.
  • the female components 126a - 126d may extend through the bottom piece 106, i.e., from the second inner face 128 to the bottom face 340.
  • the pocket 108 may be formed in the second inner face 128, and is configured for receiving the membrane 102.
  • the pocket 108 is shown more clearly in FIG. 3A.
  • FIG. 3A is a plan view of the second inner face 128 illustrated in FIG. 1 , shown without the dried biological fluid spotting membrane 102.
  • the pocket 108 has a length and a height. The length of the pocket 108 is measured along a horizontal axis 130, and is the distance between a first side wall 134 and a second side wall 136 of the pocket 108. The height of the pocket 108 is measured along a vertical axis 132, and is the distance between a top wall 138 and a bottom wall 140 of the pocket 108.
  • the length of the first window 112 may be less than the length of the pocket 108, and the height of the first window 112 may be less than the height of the pocket 108, such that the membrane 102 may be securely held between the top piece 104 and the bottom piece 106 when the top piece 104 is secured to the bottom piece 106 (i.e., when the male components 226a - 226d are detachably mated with the corresponding female components 126a - 126d).
  • FIG. 3B is a side cross-sectional elevation view of the bottom piece 106 illustrated in FIG. 3A .
  • the first window 112 ( FIGS. 1 , 2A and 2B ) is the only window of the holding device 100, and the bottom face 340 serves as a solid backing for the membrane 102 and thus may serve as a disposable punching surface.
  • the bottom face 340 may include a second window 312 formed therein.
  • the second window 312 allows a user to access the membrane 102 via the bottom face 340 of the holding device 100.
  • the second window 312 has a length and a height.
  • the length of the second window 312 is measured along the horizontal axis 130, and is the distance between a first side wall 320 and a second side wall 322 of the second window 312.
  • the height of the second window 312 is measured along the vertical axis 132, and is the distance between a top wall 324 and a bottom wall 326 of the second window 312.
  • the length of the second window 312 may be less than the length of the pocket 108, and the height of the second window 312 may be less than the height of the pocket 108.
  • the length of the second window 312 may be substantially the same as the length of the first window 112, and the height of the second window 312 may be substantially the same as the height of the first window 112.
  • the top piece 104 has a length and a height.
  • the length of the top piece 104 is measured along the horizontal axis 114, and is the distance between a first outer side wall 150 and a second outer side wall 152 of the top piece 104.
  • the height of the top piece 104 is measured along the vertical axis 120, and is the distance between an outer top wall 154 and an outer bottom wall 156 of the top piece 104.
  • the bottom piece 106 has a length and a height.
  • the length of the bottom piece 106 is measured along the horizontal axis 130, and is the distance between a first outer side wall 158 and a second outer side wall 160 of the bottom piece 106.
  • the height of the bottom piece 106 is measured along the vertical axis 132, and is the distance between an outer top wall 162 and an outer bottom wall 164 of the bottom piece 106.
  • the length of the top piece 104 and the length of the bottom piece 106 may range from about 1 inch to about 6 inches, and the height of the top piece 104 and the height of the bottom piece 106 may range from about 1 inch to about 3 inches.
  • the length and/or height of the top piece 104 may be less than the respective length and/or height of the bottom piece 106.
  • the user of the holding device 100 may easily attach the top piece 104 to the bottom piece 106 by pressing the male components 226a - 226d into the corresponding female components 126a - 126b.
  • the user of the holding device 100 may easily detach the top piece 104 from the bottom piece 106 by removing the male components 226a - 226d from the female components 126a - 126b (e.g., pulling the top piece 104 away from the bottom piece 106).
  • the membrane 102 may be positioned in the pocket 108, and the top piece 104 may then be secured to the bottom piece 106.
  • One or more dried biological fluid spots may be formed on the membrane 102.
  • a user may access the membrane 102 via the first window 112 (or, in some implementations, via the second window 312), and apply a drop(s) of a biological fluid sample to the membrane to form a biological fluid spot.
  • the biological fluid spot may be allowed to dry over a period of time.
  • a user may form a dried biological fluid spot on the membrane 102 without actually handling the membrane 102, which may decrease the likelihood of contamination of the biological fluid sample.
  • a user may extract a portion of the dried biological fluid spot (for example, by using a punch device, or any other suitable extraction apparatus) for assaying.
  • a portion of the dried biological fluid spot may be extracted (e.g., punched) via the first window 112, for example.
  • the membrane 102 does not have to be handled by a user in order to extract a portion of the dried biological fluid spot.
  • the user may detach the top piece 104 from the bottom piece 106, and remove the membrane 102 from the pocket 108.
  • the top piece 104 and bottom piece 106 may be sterilized after the membrane 102 is removed.
  • the user may position a second membrane within the pocket 108.
  • the user may secure the second membrane within the pocket 108 by detachably mating the male components 226a - 226d and the corresponding female components 126a - 126d.
  • the holding device 100 may be reused.
  • the holding device 100 does not require the use of adhesives. Since the holding device 100 is made of injection molded plastic, the holding device 100 is a durable alternative to conventional cardboard holders. For example, the plastic holding device 100 may be less likely to bend or deform during shipping, handling, automated testing, etc.
  • FIG. 4 is an exploded view of another example of a holding device 400 for the dried biological fluid spotting membrane 102 according to an implementation disclosed herein.
  • the holding device 400 includes a plastic body 402.
  • the body 402 may be composed of any suitable polymer such as described by example above, and may be formed by any suitable fabrication technique, such as injection molding.
  • the plastic body 402 includes an inner face 436, a bottom face (not shown) opposing the inner face 404 and a pocket 406 formed in the inner face 436.
  • the pocket 406 is configured for receiving the membrane 102.
  • the pocket 406 has a length and a height. The length of the pocket 406 is measured along a horizontal axis 408, and is the distance between a first side wall 410 and a second side wall 412 of the pocket 406.
  • the height of the pocket 406 is measured along a vertical axis 414, and is the distance between a top wall 416 and a bottom wall 418 of the pocket 406.
  • the holding device 400 includes a plastic laminate layer 420 that may be adhered to the inner face 436.
  • the plastic laminate layer 420 may be made of any suitable plastic material, and may be adhered to the inner face 436 by any suitable adhesive known to those skilled in the art.
  • the laminate layer 420 includes a top face 404.
  • the top face 404 includes a first window 422 therein, which allows a user to access the membrane 102 when the laminate layer 420 is adhered to the inner face 436.
  • the first window 422 has a length and a height.
  • the length of the first window 422 is measured along a horizontal axis 424, and is the distance between a first side wall 426 and a second side wall 428 of the first window 422.
  • the height of the first window 422 is measured along a vertical axis 430, and is the distance between a top wall 432 and a bottom wall 434 of the first window 422.
  • the length of the first window 422 may be less than the length of the pocket 406, and the height of the first window 422 may be less than the height of the pocket 406, such that the membrane 102 may be securely held within the pocket 406 when the laminate layer 420 is adhered to the inner face 436.
  • the bottom face of the plastic body 402 may include a second window (not shown) therein, which allows a user to access the membrane 102 via the bottom face.
  • the second window may be configured similarly to the second window 312 discussed above in conjunction with FIGS. 1- 3B .
  • FIG. 5 is a perspective view of another example of a holding device 500 for the dried biological fluid spotting membrane 102 according to the present invention.
  • the holding device 500 may include a bottom face (not shown), a top face 502, and a pocket 504 disposed between the bottom face and the top face 502, where the pocket 504 includes the membrane 102 positioned therein.
  • a bottom piece of the holding device 500 may include an inner face (not shown) and the bottom face.
  • the inner face may include the pocket 504 formed therein.
  • the pocket 504 has a length and a height. The length of the pocket 504 is measured along a horizontal axis 506, and is the distance between a first side wall 508 and a second side wall 510 of the pocket 504.
  • the height of the pocket 504 is measured along a vertical axis 512, and is the distance between a top wall 514 and a bottom wall 516 of the pocket 504.
  • the top face 502 includes a first window 518 therein, which allows a user to access the membrane 102 during dried blood spot testing, for example.
  • the first window 518 has a length and a height.
  • the length of the first window 518 is measured along the horizontal axis 506, and is the distance between a first side wall 520 and a second side wall 522 of the first window 518.
  • the height of the first window 518 is measured along the vertical axis 512, and is the distance between a top wall 524 and a bottom wall 526 of the first window 518.
  • the length of the first window 518 may be less than the length of the pocket 504, and the height of the first window 518 may be less than the height of the pocket 504, such that the membrane 102 may be more securely held within the pocket 504.
  • the bottom face may include a second window (not shown) therein, which allows a user to access the membrane 102 via the bottom face.
  • the second window may be configured similarly to the second window 312 discussed above in conjunction with FIGS. 1- 3B .
  • the holding device 500 may be made according to the steps presented below. Unless expressly provided, the following steps are presented in no particular order.
  • a bottom piece (not shown) may be injection molded.
  • the membrane 102 may be positioned within the pocket 504.
  • the top face 502 may be injection molded (or otherwise formed by a suitable fabrication technique) to the bottom piece (e.g., via overmolding, a process known by those skilled in the art).
  • a window of the holding device 100, 400 or 500 may be utilized to access the membrane 102 for various purposes. For example, one or more drops of a biological fluid sample may be applied to the membrane 102 and allowed to dry (e.g., air dry) to create one or more dried biological fluid spots. As another example, a dried biological fluid spot or a portion thereof may be extracted from the membrane 102 via the window by any suitable means.
  • a punch device may be operated to punch out a dried biological fluid sample unit (i.e., a portion of the membrane 102 containing the dried biological fluid spot or a portion of the dried biological fluid spot) from the membrane 102.
  • the holding device 100, 400 or 500 may be placed or mounted on a suitable support surface, and the punch device may then be thrust through the window and through the membrane 102 where the target dried biological fluid spot is located.
  • the punch device is typically cylindrical and thus the as-formed sample unit is typically disk-shaped. Once the sample unit has been formed it may be transported to an analytical device or any other desired destination.
  • the as-formed sample unit may be captured in the punch device and transported therewith and/or the punch device may be utilized to perform certain sample preparation procedures such as, for example, solid phase extraction, sample clean-up, etc.
  • the sample unit may be exposed to a flow of one or more elution solvents (e.g., methanol, acetonitrile, ethanol, ethyl acetate, methyl tert-butyl ether, dichloromethane, chloroform, water, etc., with or without buffers or other additives) to create an analyte-inclusive liquid sample matrix.
  • elution solvents e.g., methanol, acetonitrile, ethanol, ethyl acetate, methyl tert-butyl ether, dichloromethane, chloroform, water, etc., with or without buffers or other additives
  • the analyte-inclusive liquid sample matrix may then be processed in any desired manner for separating, concentrating, purifying, and/or analyzing the analytes (i.e., subsequent analytical techniques) eluted from the sample unit.
  • subsequent analytical techniques include, but are not limited to, protein precipitation, fraction collection, centrifugation, spectrophotometry, nuclear magnetic resonance (NMR) spectrometry, various types of SPE (e.g., normal-phase, reversed-phase, ion-exchange, etc.), and various types of chromatography (e.g., preparative chromatography, liquid chromatography (LC), gas chromatography (GC), etc.) as well as hyphenated techniques entailing mass spectrometry (LC/MS n , GC/MS n , etc.).
  • Other subsequent analytical techniques include the testing or processing of genetic material (i.e., "genetic testing") such as ribonucleic acid (RNA) or deoxyribonucleic acid (DNA).
  • PCR polymerase chain reaction
  • RT-PCR reverse transcriptase PCR
  • LCR ligase chain reaction
  • genomic sequencing labeling, assaying, etc.
  • HMW high molecular weight
  • punch devices and related devices that may be utilized in conjunction with the holding device 100, 400 or 500 include those disclosed in U.S. Patent Application Serial No. 12/916,834 , titled DRIED BIOLOGICAL FLUID SPOT PUNCH DEVICE AND RELATED METHODS, filed November 1, 2010; and U.S. Patent Application Serial No. 12/917,138 , titled APPARATUS FOR PUNCHING AND SOLID PHASE EXTRACTION OF DRIED BIOLOGICAL FLUID SPOT AND RELATED METHODS, filed November 1, 2010, both of which are incorporated herein by reference in their entireties.
  • the holding devices 100, 400 and 500 described herein provide effective means for holding the membrane 102 during dried biological fluid spot testing, such as dried blood spot testing, including automated dried blood spot testing.
  • the holding devices 100, 400 and 500 described herein provide effective means for holding the membrane 102 during shipping and handling.
  • the holding devices 100, 400 and 500 may be held or manipulated in a manner that avoids having to contact the membrane 102 and the dried biological fluid spots contained thereon, thereby avoiding contamination of the dried biological fluid spots.
  • the holding devices 100, 400 and 500 are effective in maintaining the form and/or shape of the membrane 102 during testing, thus facilitating reliable test results.
  • the present invention relates to the following items:

Landscapes

  • Health & Medical Sciences (AREA)
  • Clinical Laboratory Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Sampling And Sample Adjustment (AREA)
EP11186685A 2010-11-30 2011-10-26 Dispositif de support pour membrane de mise en place fluidique biologique séchée et procédés associés Withdrawn EP2457661A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12/956,186 US20120132560A1 (en) 2010-11-30 2010-11-30 Holding device for dried biological fluid spotting membrane and related methods

Publications (1)

Publication Number Publication Date
EP2457661A1 true EP2457661A1 (fr) 2012-05-30

Family

ID=45002616

Family Applications (1)

Application Number Title Priority Date Filing Date
EP11186685A Withdrawn EP2457661A1 (fr) 2010-11-30 2011-10-26 Dispositif de support pour membrane de mise en place fluidique biologique séchée et procédés associés

Country Status (3)

Country Link
US (1) US20120132560A1 (fr)
EP (1) EP2457661A1 (fr)
CA (1) CA2756543A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10656059B2 (en) 2018-03-07 2020-05-19 Alcala Pharmaceutical, Inc. Method for qualitative and quantitative multiplexing of drug analytes from biological samples

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9423398B2 (en) * 2011-02-08 2016-08-23 The Board Of Regents For Oklahoma State University Apparatus and method for biologic sample rapid collection and recovery device, and convenient storage
USD736403S1 (en) * 2012-02-29 2015-08-11 Agilent Technologies, Inc. Modular dried matrix spotting device

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040265187A1 (en) * 2003-01-30 2004-12-30 Davin Bradley Ferguson Blood collection slide
WO2005121745A1 (fr) * 2004-06-11 2005-12-22 Nippon Sheet Glass Company, Limited Conteneur pour biochimie
WO2010079223A1 (fr) * 2009-01-12 2010-07-15 Whatman International Limited Porte-échantillons destiné à être utilisé dans un essai biologique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB980497A (en) * 1961-06-07 1965-01-13 Du Pont A slide mount
US8652421B2 (en) * 2005-11-03 2014-02-18 Emd Millipore Corporation Immunoassay product and process

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040265187A1 (en) * 2003-01-30 2004-12-30 Davin Bradley Ferguson Blood collection slide
WO2005121745A1 (fr) * 2004-06-11 2005-12-22 Nippon Sheet Glass Company, Limited Conteneur pour biochimie
WO2010079223A1 (fr) * 2009-01-12 2010-07-15 Whatman International Limited Porte-échantillons destiné à être utilisé dans un essai biologique

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10656059B2 (en) 2018-03-07 2020-05-19 Alcala Pharmaceutical, Inc. Method for qualitative and quantitative multiplexing of drug analytes from biological samples
US11054349B2 (en) 2018-03-07 2021-07-06 Alcala Pharmaceutical, Inc. Method for preparation of dried blood sample for multiplexing of analytes

Also Published As

Publication number Publication date
CA2756543A1 (fr) 2012-05-30
US20120132560A1 (en) 2012-05-31

Similar Documents

Publication Publication Date Title
US20210373006A1 (en) Automated solid phase extraction using filter tips
EP2447699B1 (fr) Appareil pour poinçonner et extraction d'une tache de fluide biologique sec d'une phase solide et procédés correspondants
EP2447700B1 (fr) Dispositif de poinçonneur de tache de fluide biologique sec et procédés associés
EP3079819B1 (fr) Dispositif de stockage et d'extraction d'échantillons pour élution à écoulement continu d'analytes
WO2017027425A1 (fr) Système modulaire de manipulation de liquides
US20130028814A1 (en) Porous filter column and reagent cartridge and nucleic acid purification kit using the same
EP2546629A2 (fr) Appareil et procédés pour l'acquisition d'analytes dans un échantillon de fluide biologique séché
US20040245163A1 (en) Purification device for ribonucleic acid in large volumes, and method
US20150047441A1 (en) Sample carrier for dried biological samples
US20200103316A1 (en) Sample Collection Device
JP2015195784A (ja) 多孔質フィルターカラム、試薬カートリッジ及び核酸抽出キット
EP2457661A1 (fr) Dispositif de support pour membrane de mise en place fluidique biologique séchée et procédés associés
WO2006104905A1 (fr) Dispositif permettant de maintenir un echantillon et de soumettre cet echantillon a une analyse chromatographique
EP3970859A1 (fr) Dispositifs à membrane pour la filtration et l'extraction
EP1804972A2 (fr) Cartouche multiple, structure d'agencement de cartouche, et contenant de recuperation
US20230075131A1 (en) Automated solid phase extraction using filter tips
EP4397412A1 (fr) Procédé d'extraction sous vide à haut débit
US20240271198A1 (en) Device and method for processing biological samples
EP2525909A1 (fr) Articles en matière plastique pour analyse, consommables, comportant des matières plastiques de haute solubilité
EP2409160A2 (fr) Systèmes et procédés de traitement de lamelles

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20121201